Crestline Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,840
Closed -$387K 833
2024
Q3
$387K Buy
+18,840
New +$387K 0.02% 414